![]() Viking Therapeutics Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of therapies for metabolic and endocrine disorders. | ![]() Lobesity Lobesity (also known as Lobesity Investors) is a company engaged in the clinical and commercial development of therapies to treat obesity and related disorders. | Apoglyx Apoglyx is a biotech company developing a small molecule oral therapy for type 2 diabetes patients. | ||
Founding Date | Founding Date 2012 | Founding Date 2015 | Founding Date 2015 | Founding Date 2011 |
Type | Type Public | Type Private | Type Private | Type Public |
Tags | ||||
Locations | Locations San Diego, US HQ | Locations Cleveland, US HQ | Locations Malmö, SE HQ Lund, SE | Locations Shanghai, CN HQ Beijing, CN Wuhan, CN Hong Kong, HK |
Employees | Employees 2729% increase | Employees 1 | Employees 525% increase | Employees 168 |
Financial | ||||
Net income | Net income ($359.6m) (FY, 2025) | Net income N/A | Net income N/A | Net income ¥1.1b (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised $ 15m | Total funding raised $ 722.5k | Total funding raised N/A | Total funding raised $ 242.4m |

Lobesity (also known as Lobesity Investors) is a company engaged in the clinical and commercial development of therapies to treat obesity and related disorders.
View companyApoglyx is a biotech company developing a small molecule oral therapy for type 2 diabetes patients.
View company
Hua Medicine (华领医药) is a drug development company.
View company